You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate and what is the scope of patent protection?

Sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate is the generic ingredient in three branded drugs marketed by Novel Labs Inc and Salix Pharms, and is included in three NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate has twenty-nine patent family members in eleven countries.

Summary for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

International Patents:	29
US Patents:	1
Tradenames:	3
Applicants:	2
NDAs:	3
DailyMed Link:	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE at DailyMed

Pharmacology for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Drug Class	Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Anatomical Therapeutic Chemical (ATC) Classes for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Paragraph IV (Patent) Challenges for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OSMOPREP	Tablets	sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate	1.102 g and 0.398 g	021892	1	2008-04-09

US Patents and Regulatory Information for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novel Labs Inc	MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE	sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate	TABLET;ORAL	079247-001	Dec 30, 2011		RX	No	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Salix Pharms	VISICOL	sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate	TABLET;ORAL	021097-001	Sep 21, 2000		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Salix Pharms	OSMOPREP	sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate	TABLET;ORAL	021892-001	Mar 16, 2006		DISCN	Yes	No	7,687,075	⤷ Subscribe	Y	Y		⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Salix Pharms	OSMOPREP	sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate	TABLET;ORAL	021892-001	Mar 16, 2006	5,616,346	⤷ Subscribe
Salix Pharms	VISICOL	sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate	TABLET;ORAL	021097-001	Sep 21, 2000	5,616,346	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Canada	2814523	COMPOSITION PURGATIVE POUR LE COLON A AGENT DE LIAISON SOLUBLE (COLONIC PURGATIVE COMPOSITION WITH SOLUBLE BINDING AGENT)	⤷ Subscribe
World Intellectual Property Organization (WIPO)	2005051361		⤷ Subscribe
South Korea	20060114342	COLONIC PURGATIVE COMPOSITION WITH SOLUBLE BINDING AGENT	⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2203431	92666	Luxembourg	⤷ Subscribe	PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119
1259550	08C0052	France	⤷ Subscribe	PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
2932970	1890039-9	Sweden	⤷ Subscribe	PRODUCT NAME: DOLUTEGRAVIR SODIUM + RILPIVIRINE HYDROCHLORIDE; REG. NO/DATE: EU/1/18/1282 20180518
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Market Analysis and Financial Projection Experimental

Sodium Phosphate Dibasic and Monobasic: Market Dynamics and Financial Trajectory

Introduction

Sodium phosphate dibasic and monobasic are versatile chemical compounds with widespread applications in various industries, including food and beverages, pharmaceuticals, and water treatment. This article delves into the market dynamics, financial trajectory, and key trends influencing these compounds.

Market Size and Projections

The sodium phosphate dibasic market is experiencing significant growth. As of 2023, the market size was valued at USD 1.43 billion and is projected to reach USD 3.93 billion by 2031, growing at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2031[1][4].

Key Applications

Food and Beverages

Sodium phosphate dibasic is extensively used in the food industry as a food additive to improve texture and stability. It is particularly important in dairy, baked goods, and meat processing, where it acts as a buffering agent, emulsifier, and nutrient[1][4].

Pharmaceuticals

In the pharmaceutical sector, sodium phosphate dibasic is used as a pH buffer and stabilizer in various formulations. Its ability to regulate pH levels and enhance solubility makes it a valuable ingredient in drug manufacturing[1][4].

Water Treatment

The compound is also used in water treatment processes as a scale inhibitor, contributing to the growing demand driven by health and hygiene standards in emerging countries[1].

Market Drivers

Increasing Demand in Food and Pharma

The rising demand for processed foods and pharmaceutical products is a significant driver of the sodium phosphate dibasic market. Consumer preferences for convenient and high-quality products have increased the need for this compound in food and drug formulations[4].

Regulatory Frameworks

Stringent regulations in the food and pharmaceutical industries ensure product safety and quality, fostering trust and credibility in the market. Compliance with these regulations positions companies favorably for investment opportunities[4].

Technological Advancements

Improvements in production techniques, such as higher purity levels and reduced environmental impact, are making sodium phosphate dibasic more competitive. Companies are investing in sustainable sourcing and production methods, aligning with global sustainability goals[1][4].

Market Segmentation

Product Forms

The sodium phosphate dibasic market is segmented based on product forms such as anhydrous, dihydrate, heptahydrate, trihydrate, and purified forms. Each form has specific applications and market demand[1].

End-Use Industries

The market is also segmented by end-use industries, including food and beverages, pharmaceuticals, water treatment, detergents, and metal treatment. The pharmaceutical segment is particularly dominant due to the increasing demand for pharmaceutical products[1].

Geographical Regions

The market is geographically segmented into North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. The Asia-Pacific region is expected to be dominant due to increasing manufacturing activities in this region[1].

Financial Trajectory

Revenue Growth

The projected revenue growth of the sodium phosphate dibasic market from USD 1.43 billion in 2023 to USD 3.93 billion by 2031 indicates a robust financial trajectory. This growth is driven by the compound's diverse applications and increasing demand from various industries[1][4].

Investment Opportunities

The growing demand in the food and pharmaceutical sectors, coupled with ongoing research and development, presents lucrative investment opportunities. Companies are exploring innovative applications and formulations, which is expected to further accelerate market growth[4].

Sustainability and Eco-Friendly Practices

The focus on sustainability is a growing trend in the sodium phosphate dibasic market. Manufacturers are adopting eco-friendly practices, such as using renewable resources and minimizing waste during production. This aligns with global sustainability goals and appeals to environmentally conscious consumers and businesses[4].

Regulatory Compliance

Regulatory frameworks play a crucial role in ensuring product safety and quality. Compliance with these regulations enhances product safety and positions companies favorably for investment opportunities. This compliance also fosters trust and credibility in the market[4].

Recent Trends and Innovations

Innovations in Food Technology

Recent advancements in food technology have created new opportunities for sodium phosphate dibasic. The compound's role in enhancing food texture and stability is becoming increasingly vital as consumer preferences shift towards convenient and high-quality products[4].

Strategic Collaborations

Strategic collaborations between industry players are another trend influencing the market. These collaborations are driving innovation and development, positioning sodium phosphate dibasic as a key ingredient in modern formulations[4].

Sodium Phosphate Monobasic

Market Dynamics

While the focus is on sodium phosphate dibasic, sodium phosphate monobasic also plays a significant role in various applications. It is used as a drug excipient and in pharmaceutical formulations where its properties as a buffering agent and nutrient are valuable[3].

Business Development Opportunities

For excipient manufacturers, the sodium phosphate monobasic market offers business development opportunities. The DrugPatentWatch Excipient Business Development Opportunity Report provides insights into drugs containing this excipient, facilitating communication and collaboration with potential buyers[3].

Key Takeaways

The sodium phosphate dibasic market is projected to grow significantly, reaching USD 3.93 billion by 2031.
Key applications include food and beverages, pharmaceuticals, and water treatment.
Market drivers include increasing demand in food and pharma, regulatory frameworks, and technological advancements.
Sustainability and eco-friendly practices are becoming increasingly important.
Strategic collaborations and innovations in food technology are driving market growth.

FAQs

What are the primary applications of sodium phosphate dibasic?

Sodium phosphate dibasic is primarily used in the food and beverage industry as a food additive, in pharmaceuticals as a pH buffer, and in water treatment as a scale inhibitor[1][4].

How is the sodium phosphate dibasic market segmented?

The market is segmented by product forms (anhydrous, dihydrate, etc.), end-use industries (food and beverages, pharmaceuticals, etc.), and geographical regions (North America, Europe, etc.)[1].

What is driving the growth of the sodium phosphate dibasic market?

The growth is driven by increasing demand in the food and pharmaceutical sectors, stringent regulatory frameworks, and technological advancements in production techniques[1][4].

What role does sustainability play in the sodium phosphate dibasic market?

Sustainability is a growing focus, with manufacturers adopting eco-friendly practices such as using renewable resources and minimizing waste during production. This aligns with global sustainability goals and appeals to environmentally conscious consumers and businesses[4].

What are the investment opportunities in the sodium phosphate dibasic market?

Investment opportunities exist in the growing demand from the food and pharmaceutical sectors, coupled with ongoing research and development. Companies are exploring innovative applications and formulations, which is expected to further accelerate market growth[4].

Sources

Market Research Intellect, "Sodium Phosphate Dibasic Market Size and Forecast", December 2024.
Coherent Market Insights, "Anhydrous Dibasic Calcium Phosphate Market Size & Share Analysis", 2023.
DrugPatentWatch, "SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024".
Market Research Intellect, "Sodium Phosphate Dibasic Market Grows as Demand for Food and Pharma Applications Increases", October 2024.
DrugBank Online, "Sodium phosphate, dibasic - Search Results".

More… ↓

⤷ Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.